Advertisement

Radionuclide Imaging of Degenerative Joint Diseases

  • Klaus Strobel

Abstract

The incidence of degenerative joint diseases increases with age and therapeutic procedures such as joint replacement are expensive [1]. Conventional bone scintigraphy with Tc99m-phosponates is very sensitive in the diagnosis of osteoarthritis. SPECT, SPECT/CT, and 18F-fluoride PET(/CT) increase the performance of planar bone scintigraphy and provide brilliant images even in complex anatomic regions such as the spine or the foot [2, 3, 4]. Differentiation between degenerative joint disease and bone metastases is one of the most important questions in clinical practice. Since uptake in scintigraphy does not always correspond with the symptoms of the patient, exact clinical correlation is crucial.

Keywords

Bone Metastasis Bone Scintigraphy Radionuclide Image Degenerative Lesion Bone Marrow Change 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    MacLean CH, Knight K, Paulus H et al (1998) Costs attributable to osteoarthritis. J Rheumatol 25:2213–2218PubMedGoogle Scholar
  2. 2.
    Strobel K, Burger C, Seifert B et al (2007) Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT. AJR Am J Roentgenol 188:W467–W474CrossRefPubMedGoogle Scholar
  3. 3.
    Utsunomiya D, Shiraishi S, Imuta M et al (2006) Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology 238:264–271CrossRefPubMedGoogle Scholar
  4. 4.
    Romer W, Nomayr A, Uder M et al (2006) SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. J Nucl Med 47:1102–1106PubMedGoogle Scholar
  5. 5.
    Kim DW, Kim SC, Krynyckyi BR et al (2005) Focally increased activity in the lateral aspect of the mid cervical spine on bone scintigraphy is almost always benign in nature. Clin Nucl Med 30:593–595CrossRefPubMedGoogle Scholar
  6. 6.
    Pneumaticos SG, Chatziioannou SN, Hipp JA et al (2006) Low back pain: prediction of short-term outcome of facet joint injection with bone scintigraphy. Radiology 238:693–698CrossRefPubMedGoogle Scholar
  7. 7.
    Dolan AL, Ryan PJ, Arden NK et al (1996) The value of SPECT scans in identifying back pain likely to benefit from facet joint injection. Br J Rheumatol 35:1269–1273CrossRefPubMedGoogle Scholar
  8. 8.
    Buck FM, Hoffmann A, Hofer B et al (2008) Chronic medial knee pain without history of prior trauma: correlation of pain at rest and during exercise using bone scintigraphy and MR imaging. Skeletal Radiol Dec 3 [Epub ahead of print]Google Scholar
  9. 9.
    Boegard T, Rudling O, Dahlstrom J et al (1999) Bone scintigraphy in chronic knee pain: comparison with magnetic resonance imaging. Ann Rheum Dis 58:20–26CrossRefPubMedGoogle Scholar
  10. 10.
    Lorberboym M, Ami DB, Zin D et al (2003) Incremental diagnostic value of 99mTc methylene diphosphonate bone SPECT in patients with patellofemoral pain disorders. Nucl Med Commun 24:403–410CrossRefPubMedGoogle Scholar
  11. 11.
    Nakamura H, Masuko K, Yudoh K et al (2007) Positron emission tomography with 18F-FDG in osteoarthritic knee. Osteoarthritis Cartilage 15:673–681CrossRefPubMedGoogle Scholar
  12. 12.
    Rosen RS, Fayad L, Wahl RL (2006) Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT. J Nucl Med 47:1274–1280PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Klaus Strobel
    • 1
  1. 1.Department of Nuclear MedicineUniversity Hospital ZurichSwitzerland

Personalised recommendations